A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebili — Stacey Lynn Clardy (UTAH ST
N-methyl-D-aspartate receptor (NMDAR) encephalitis is one of the most common causes of autoimmune encephalitis, with prevalence exceeding herpes encephalitis in industrialized nations. Typically, the
| Project title | A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebili |
|---|---|
| Project number | 5U01NS120901-03 |
| PI name | Stacey Lynn Clardy |
| Institution | UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH |
| Funding mechanism | U01 |
| Agency | NINDS |
| Award amount | $3.64M |
| Fiscal year | 2024 |
| Project start | 2021-09-15T00:00:00 |
| Project end | 2027-08-31T00:00:00 |
| Abstract | N-methyl-D-aspartate receptor (NMDAR) encephalitis is one of the most common causes of autoimmune encephalitis, with prevalence exceeding herpes encephalitis in industrialized nations. Typically, the |
| Key terms | <7S Gamma Globulin><Ab response><Accounting><Acute><Address><Admission><Admission activity><Adverse |
$799/mo
Try GrantRadar →